Bicycle Therapeutics Plc ADR (BCYC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 11,734 | 2,920 | 9,977 | 3,708 | 2,676 |
| Gross Profit | 11,734 | 2,920 | 9,977 | 3,708 | 2,676 |
| Operating Expenses | 77,285 | 89,522 | 80,181 | 71,371 | 66,522 |
| Operating Income | -65,551 | -86,602 | -70,204 | -67,663 | -63,846 |
| Interest Expense | 44 | 54 | 51 | 52 | 33 |
| Other Income | 6,700 | 7,473 | 8,414 | 14,779 | 9,629 |
| Pre-tax Income | -58,895 | -79,183 | -61,841 | -52,936 | -54,250 |
| Income Tax | 205 | -231 | -1,087 | -1,082 | -3,448 |
| Net Income Continuous | -59,100 | -78,952 | -60,754 | -51,854 | -50,802 |
| Net Income | $-59,100 | $-78,952 | $-60,754 | $-51,854 | $-50,802 |
| EPS Basic Total Ops | -0.85 | -1.14 | -0.88 | -0.77 | -0.74 |
| EPS Basic Continuous Ops | -0.85 | -1.14 | -0.88 | -0.78 | -0.74 |
| EPS Diluted Total Ops | -0.85 | -1.14 | -0.88 | -0.77 | -0.74 |
| EPS Diluted Continuous Ops | -0.85 | -1.14 | -0.88 | -0.78 | -0.74 |
| EPS Diluted Before Non-Recurring Items | -0.85 | -1.14 | -0.88 | -0.80 | -0.74 |
| EBITDA(a) | $-63,795 | $-84,906 | $-68,570 | $-65,959 | $-61,674 |